Nexsen Limited (ASX: NXN)
Health Care · Biotechnology · AU
AU$0.24
+11.63% today · -14.3% 1Y
Nexsen Limited (ASX: NXN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $34.06M.
Over the last twelve months the share price has lost 14.3%, trading between 0.13 and 0.35.
NXN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $34.06M
- Revenue (TTM)
- $621.40K
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- AU$0.35
- 52-week low
- AU$0.13
- Avg volume (3M)
- —
- Shares outstanding
- 200.20M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.53 | -1.60% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $440.95 | -0.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $147.78 | -0.67% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $548.74 | -0.74% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $827.02 | -0.78% |
| argenx SEENXTBR: ARGX | $64.17B | €895.40 | +1.84% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $150.71 | -5.11% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.